HNGE Form 144: 15,000‑Share 10b5-1 Sale Listed

HNGE filing reports a broker notice of proposed resale of 82,000 Performance Stock Units and records a 10b5-1 market sale by James Pursley of 15,000 common shares on 03/23/2026 for $633,927.

Rhea-AI Filing Summary

HNGE filing reports a broker notice of proposed resale of 82,000 Performance Stock Units and records a 10b5-1 market sale by James Pursley of 15,000 common shares on 03/23/2026 for $633,927. The filing lists a reference figure of 54,655,926 (dated 05/26/2026) as a context number.

Insights

Securities Compliance Analyst

Form 144 records a planned resale and a recent Rule 10b5-1 sale by an insider.

The filing lists 82,000 Performance Stock Units tied to an issuer schedule dated 04/01/2023 and documents a 10b5-1 sale by James Pursley of 15,000 shares on 03/23/2026 for $633,927. The notice includes a separate numeric line 54,655,926 with an associated date of 05/26/2026, which appears as a context figure.

Cash‑flow treatment and whether proceeds benefit the issuer or selling holder are not specified in the excerpt; subsequent filings or transaction confirmations would provide settlement details and any withholding or broker information.

Key Figures

10b5-1 sale: 15,000 shares Proceeds reported: $633,927 Performance Stock Units listed: 82,000 +1 more

4 metrics

10b5-1 sale 15,000 shares sale by James Pursley on 03/23/2026

Proceeds reported $633,927 proceeds from 10b5-1 sale on 03/23/2026

Performance Stock Units listed 82,000 Performance Stock Units line dated 04/01/2023

Reference numeric line 54,655,926 numeric line associated with 05/26/2026

Key Terms

10b5-1, Performance Stock Units, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for JAMES PURSLEY 455 Market Street"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Performance Stock Units financial

"Performance Stock Units | Issuer | 82000 | 04/01/2023"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does HNGE's Form 144 show about recent insider selling?

The Form 144 records a Rule 10b5-1 sale by James Pursley of 15,000 shares on 03/23/2026, with proceeds of $633,927. This entry documents the intended resale; settlement details are not included in the excerpt.

How many Performance Stock Units are listed in the HNGE filing?

The filing lists 82,000 Performance Stock Units associated with an issuer schedule dated 04/01/2023. The units are shown as a security line in the notice; the excerpt does not state conversion timing or vesting status.

Does the Form 144 disclose shares outstanding for HNGE?

The excerpt includes the figure 54,655,926 with a date of 05/26/2026 which appears as an informational line. The filing does not explicitly label that number as "shares outstanding" within the provided excerpt.

Was the James Pursley sale part of a prearranged plan?

Yes. The sale by James Pursley is identified as a 10b5-1 sale on 03/23/2026. The excerpt lists the 10b5-1 mechanism; further plan terms or adoption date are not included here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 04:41 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001783108
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	JAMES PURSLEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	82000	4530500.00	54655926	05/26/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2023	Performance Stock Units	Issuer			82000	04/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES PURSLEY 455 Market Street, Suite 700 San Francisco CA 94105	Common	03/23/2026	15000	633927.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of performance stock units during the period of 4/1/2023 through 3/31/2025.
Date of Notice	05/26/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Pursley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)